Disclosed in the present invention are an application of 5a-androst-3ß,5,6ß-triol and an analogue, a deuterated substitute, or a pharmaceutically acceptable salt thereof in the preparation of a drug for the treatment of haemorrhagic stroke. The haemorrhagic stroke is a brain parenchymal haemorrhage, a subarachnoid haemorrhage, or both.